News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
109–144
Matches
304
Sources here
16
Companies here
12
Search results Stored financial headlines

Active search

304 matching headlines

Ticker or company: NHIMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

SABESP Partners with Vivo and IDEMIA Secure Transactions, to Power the World's Largest IoT Initiative for a Secure and More Sustainable Water Management in Brazil

SABESP, the water and sanitation company of the State of São Paulo, Brazil, announces the deployment of the world's largest Internet of Things (IoT) connectivity project for smart water management. The initiative is being implemented in partnership with Telefonica/Vivo, a key player in Brazil's …

SBS main company
Sharemaestro market context Price below Trend Line 52 weeks +10.9% SBS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Gráfico Cia Energetica Minas Gerais Cemig (CMIG4)

This page displays the live stock chart for Cia Energetica Minas Gerais Cemig (CMIG4) on the BOV exchange. It provides current stock data, including the latest price, daily change, and closing time. The page also offers various tools and information related to CMIG4, such …

CIG main company
Sharemaestro market context Price below Trend Line 52 weeks +7.0% CIG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Inhibrx Biosciences (INBX) sees 5.9% ownership reported by Bank of America

Bank of America Corporation has reported a beneficial ownership of 857,318 shares of Inhibrx Biosciences (INBX) common stock, which represents 5.9% of the class. This ownership is held through various affiliated entities, including BofA Securities, Inc., Bank of America, N.A., Merrill Lynch International, Merrill …

INBX main company
Sharemaestro market context Price above Trend Line 52 weeks +253.5% INBX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

National Health Investors (NHI) Expected to Release Quarterly Earnings on Monday

National Health Investors (NHI) is scheduled to release its Q2 2026 earnings on Monday, August 10th, with analysts forecasting earnings per share of $0.843 and revenue of $72.1 million. The stock opened at $76.81, below the consensus price target of $83.86, despite a "Moderate …

NHI main company
Sharemaestro market context Price below Trend Line 52 weeks -3.0% · Next-week setup positive 58.6% NHI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Q1 2026 Companhia de Saneamento Basico do Estado de Sao Paulo - SABESP Earnings Call (English, Portuguese) Transcript

Companhia de Saneamento Basico do Estado de Sao Paulo (SABESP) reported strong financial results for Q1 2026, with adjusted net revenue increasing 11% year-on-year to $6 billion and adjusted EBITDA up 26% to $3.8 billion. The company highlighted increased CapEx, a robust liquidity position, …

SBSP3 main company SBSP3 main company SBS main company
Sharemaestro market context Price below Trend Line 48 weeks -73.8% SBSP3 stored weekly price path from 8 Aug 2025 to 14 Aug 2026

Perceptive Advisors LLC Sells 3,106,568 Shares of Inhibikase Therapeutics, Inc. $IKT

Perceptive Advisors LLC significantly reduced its stake in Inhibikase Therapeutics (NASDAQ:IKT) by selling over 3.1 million shares, though other institutional investors like Sands Capital Alternatives and ADAR1 Capital Management increased their holdings. Despite this sale, analyst sentiment remains largely positive with an average "Buy" …

IKT main company
Sharemaestro market context Trend signal active 52 weeks +27.5% IKT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Dimensional Fund Advisors LP Grows Stock Holdings in National Health Investors, Inc. $NHI

Dimensional Fund Advisors LP increased its stake in National Health Investors, Inc. (NHI) by 2.7% in the first quarter, now holding 686,249 shares valued at $55.5 million. Institutional investors own 62.51% of NHI, which also saw share purchases by company insiders including its CEO. …

NHI main company
Sharemaestro market context Price below Trend Line 52 weeks -3.0% · Next-week setup positive 58.6% NHI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Companhia Paranaense de Energia - Copel Unsponsored ADR (NYSE:ELPC) Short Interest Up 64.9% in July

Companhia Paranaense de Energia - Copel Unsponsored ADR (NYSE:ELPC) experienced a significant 64.9% increase in short interest during July, totaling 629,886 shares as of July 15th. This represents about 0.1% of the company's shares and 1.5 days to cover based on average trading volume. …

ELPC main company
Sharemaestro market context Trend signal ended 52 weeks +37.4% ELPC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Companhia Siderurgica Nacional Revenue Breakdown – BMFBOVESPA:CSNA3

This article provides a revenue breakdown for Companhia Siderurgica Nacional (BMFBOVESPA:CSNA3). It highlights that the company generated 44.80 billion BRL last year, with the Steel segment being the top performer, contributing 22.03 billion BRL. The largest regional contribution came from Brazil, accounting for 22.29 …

SID main company
Sharemaestro market context Price below Trend Line 52 weeks -33.4% SID stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp (NYSE:SBS) Downgraded to "Hold" Rating by Wall Street Zen

Wall Street Zen and Zacks Research have both downgraded Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp (NYSE:SBS) to a "Hold" rating, though the consensus among analysts remains a "Moderate Buy" with a $183 price target. The downgrades follow SABESP reporting …

SBS main company
Sharemaestro market context Price below Trend Line 52 weeks +10.9% SBS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Inhibikase Therapeutics, Inc. Revenue Breakdown – NASDAQ:IKT

This article provides a basic financial overview for Inhibikase Therapeutics, Inc. (NASDAQ:IKT) on TradingView. It indicates that the market is closed, with no current trades. The content primarily lists available financial data categories and links to various TradingView products and community features, rather than …

IKT main company
Sharemaestro market context Trend signal active 52 weeks +27.5% IKT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

18,030,000-share swap for warrant by Inhibikase Therapeutics, Inc. (IKT)

RA Capital Healthcare Fund, L.P., a ten percent owner of Inhibikase Therapeutics, Inc. (IKT), executed an Exchange Agreement on July 29, 2026. The fund swapped 18,030,000 shares of common stock for a pre-funded warrant exercisable for the same number of shares at $0.001 per …

IKT main company
Sharemaestro market context Trend signal active 52 weeks +27.5% IKT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

RA Capital group (NASDAQ: IKT) discloses 9.99% capped stake via stock and warrants

RA Capital Management, L.P., along with RA Capital Healthcare Fund, L.P., Peter Kolchinsky, and Rajeev Shah, have disclosed a beneficial ownership of 14,653,994 shares, capped at 9.99%, in Inhibikase Therapeutics, Inc. (IKT) through stock and pre-funded warrants. The pre-funded warrants include a "Beneficial Ownership …

IKT main company
Sharemaestro market context Trend signal active 52 weeks +27.5% IKT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

(NHI) as a Liquidity Pulse for Institutional Tactics

This article analyzes National Health Investors Inc. (NYSE: NHI) using AI models to provide institutional trading strategies. It highlights conflicting sentiment, a mid-channel oscillation pattern, and an exceptional risk-reward short setup. The analysis includes position trading, momentum breakout, and risk hedging strategies, along with …

NHI main company
Sharemaestro market context Price below Trend Line 52 weeks -3.0% · Next-week setup positive 58.6% NHI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

SABESP (SBS) investors face conditional EMAE share merger pending EMAE vote

SABESP shareholders have approved the merger of all EMAE shares not already held by SABESP into SABESP, with EMAE shareholders set to receive SABESP common shares. However, the effectiveness of this merger is conditional upon approval by EMAE's own Extraordinary General Shareholders' Meeting, which …

SBS main company
Sharemaestro market context Price below Trend Line 52 weeks +10.9% SBS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

H.C. Wainwright reiterates Inhibikase stock rating on FDA orphan drug status

H.C. Wainwright has reiterated a Buy rating and an $8.00 price target for Inhibikase Therapeutics Inc (NASDAQ:IKT) after the company received FDA Orphan Drug Designation for IKT-001, its lead product candidate for pulmonary arterial hypertension. This designation provides significant incentives and potential market exclusivity. …

IKT main company
Sharemaestro market context Trend signal active 52 weeks +27.5% IKT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Announcement of Private Exchange Offer for Any and All of CSN Inova Ventures’ Outstanding 6.750% Senior Notes due 2028 and Consent Solicitation

São Paulo, July 30, 2026 (GLOBE NEWSWIRE) -- Companhia Siderúrgica Nacional (“CSN”) (NYSE: SID) announced today that its subsidiary, CSN Inova Ventures (formerly CSN Islands XI Corp.) (the “Issuer”), an exempted company incorporated under the laws of the Cayman Islands and a direct wholly-owned …

SID main company
Sharemaestro market context Price below Trend Line 52 weeks -33.4% SID stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Eligible CSN Noteholders Offered $253.85 Cash Plus New Notes

CSN Inova Ventures, a subsidiary of Companhia Siderúrgica Nacional (NYSE: SID), has launched a private exchange offer for its outstanding $1.3 billion 6.750% Senior Notes due 2028. Eligible holders who tender their notes by August 10, 2026, will receive $746.15 in new 11.000% Senior …

SID main company
Sharemaestro market context Price below Trend Line 52 weeks -33.4% SID stored weekly price path from 22 Aug 2025 to 14 Aug 2026

National Health Investors (NYSE: NHI) COO submits initial Form 3

National Health Investors Inc.'s Chief Operating Officer, Christian Ken Maingot, has filed an initial Form 3, an "Initial Statement of Beneficial Ownership." This filing indicates his position as COO but shows no reportable non-derivative or derivative securities currently owned by him, establishing a baseline …

NHI main company
Sharemaestro market context Price below Trend Line 52 weeks -3.0% · Next-week setup positive 58.6% NHI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

National Health Investors (NYSE: NHI) awards COO 2,370 restricted shares

National Health Investors (NYSE: NHI) has awarded its Chief Operating Officer, Christian Ken Maingot, 2,370 shares of restricted common stock. This grant, made on July 27, 2026, vests in three equal annual installments starting July 27, 2027, provided his continued service to the company. …

NHI main company
Sharemaestro market context Price below Trend Line 52 weeks -3.0% · Next-week setup positive 58.6% NHI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Companhia Siderurgica Number of Employees 2026 | Employee Count & Headcount Data

Companhia Siderurgica Nacional (CSNA3) had approximately 38,249 employees worldwide as of March 2026, representing a 6.1% growth from 2023 but a 0.6% decline year-over-year in 2026. The company is actively hiring, with 267 active job postings in 2026, though this is an 8.9% decline …

CSNA3 main company SID main company
Sharemaestro market context Price below Trend Line 52 weeks -18.1% CSNA3 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Inhibrx Biosciences Inc (INBX) Institutional Confidence

The article analyzes the institutional confidence score for Inhibrx Biosciences Inc (INBX), which currently stands at 7.00, placing it 80th in its industry. Institutional shareholding has increased to 84.51%, with Andreas Halvorsen being the largest shareholder. The report also lists other significant institutional shareholders …

INBX main company
Sharemaestro market context Price above Trend Line 52 weeks +253.5% INBX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Inhibikase Therapeutics Inc (IKT) Financial Health: Profitability & Balance Sheet Analysis

This article provides an analysis of Inhibikase Therapeutics Inc's (IKT) financial health, ranking it 237 out of 384 in the Biotechnology & Medical Research industry. The company's financial status is described as robust, but its operating efficiency is low. Key financial metrics such as …

IKT main company
Sharemaestro market context Trend signal active 52 weeks +27.5% IKT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp (NYSE:SBS) Short Interest Down 43.9% in July

Short interest in Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp (NYSE:SBS) decreased by 43.9% in July to 14.5 million shares, representing 0.4% of shares outstanding. Despite analyst "Buy" ratings and a target of $183.00, the company's recent earnings missed expectations, …

SBS main company SBS main company
Sharemaestro market context Trend signal ended 52 weeks +27.9% · Next-week setup positive 59.5% SBS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

What National Health Investors (NHI)'s New COO Appointment Means For Shareholders

National Health Investors (NHI) has appointed Chris Maingot as Chief Operating Officer, a move seen as aligning with the company's priorities in senior housing. Maingot's 20 years of experience in senior housing is expected to influence NHI's portfolio optimization and capital allocation, particularly as …

NHI main company
Sharemaestro market context Price below Trend Line 52 weeks -3.0% · Next-week setup positive 58.6% NHI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Inhibrx Biosciences (INBX) Expands Its Credit Facility, Is The Valuation Risk Priced In?

Inhibrx Biosciences (INBX) recently expanded its credit facility to $500 million, leading to a reassessment of its valuation by investors, despite a strong year-to-date return. The company's high price-to-book ratio of 55.6x, compared to an industry average of 2.4x, reflects its negative equity and …

INBX main company
Sharemaestro market context Price above Trend Line 52 weeks +253.5% INBX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Inhibrx Biosciences Market Sentiment

The article provides a market sentiment overview for Inhibrx Biosciences (INBX), detailing analyst consensus, short interest, and recent analyst actions. Key signals indicate a "Buy" consensus from analysts with a significant upside on the price target, alongside a high short interest percentage. The analyst …

INBX main company
Sharemaestro market context Price above Trend Line 52 weeks +253.5% INBX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp $SBS Shares Sold by First Trust Advisors LP

First Trust Advisors LP significantly reduced its stake in Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp ($SBS) by 27.1% in the first quarter, selling over 308,000 shares. Despite this, other institutional investors like VPR Management LLC and Creative Planning increased …

SBS main company
Sharemaestro market context Price below Trend Line 52 weeks +10.9% SBS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ADAR1 Capital Management LLC Reduces Stock Position in Inhibikase Therapeutics, Inc. $IKT

ADAR1 Capital Management LLC significantly reduced its stake in Inhibikase Therapeutics (NASDAQ:IKT) by 18.1% in the first quarter, selling over 1.4 million shares. Despite this reduction, other institutional investors like BNP Paribas Financial Markets, Barclays PLC, and Virtu Financial LLC increased their positions. The …

IKT main company
Sharemaestro market context Trend signal active 52 weeks +27.5% IKT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context